Glycopeptides: An old but up-to-date successful antibiotic class

Antimicrobials: New and Old Molecules in the Fight Against Multi-Resistant Bacteria

Volumn 9783642399688, Issue , 2014, Pages 85-107

  Marcone, Giorgia Letizia ^a   Marinelli, Flavia ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930246642     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-39968-8_5     Document Type: Chapter

References (100)

1. Arnusch CJ, Bonvin AM, Verel AM, Jansen WT, Liskamp RM, de Kruijff B, Pieters RJ, Breukink E (2008) The vancomycin-nisin (1-12) hybrid restores activity against vancomycin resistant enterococci. Biochemistry 47:12661-12663
2. Arthur M, Reynolds PE, Depardieu F, Evers S, Dutka-Malen S, Quintiliani R, Courvalin P (1996) Mechanisms of glycopeptide resistance in enterococci. J Infect 32:11-16
3. Ashford PA, Bew SP (2012) Recent advances in the synthesis of new glycopeptide antibiotics. Chem Soc Rev 41:957-978
4. Bager F, Aarestrup FM, Madsen M, Wegener HC (1999) Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin. Microb Drug Resist 5:53-56
5. Banik JJ, Brady SF (2008) Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary. Proc Natl Acad Sci USA 105:17273-17277
6. Banik JJ, Craig JW, Calle PY, Brady SF (2010) Tailoring enzyme-rich environmental DNA clones: A source of enzymes for generating libraries of unnatural natural products. J Am Chem Soc 132:15661-15670
7. Belley A, McKay GA, Arhin FF, Sarmiento I, Beaulieu S, Fadhil I, Parr TR, Moeck G (2010) Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing. Antimicrob Agents Chemother 54:5369-5371
8. Beltrametti F, Consolandi A, Carrano L, Bagatin F, Rossi R, Leoni L, Zennaro E, Selva E, Marinelli F (2007) Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan. Antimicrob Agents Chemother 51:1135-1141
9. Binda E, Marcone GL, Pollegioni L, Marinelli F (2012) Characterization of VanYn, a novel D, Dpeptidase/ D, D-carboxypeptidase involved in glycopeptide antibiotic resistance in Nonomuraea sp. ATCC 39727. FEBS J 279:3203-3213
10. Binda E, Marcone GL, Berini F, Pollegioni L, Marinelli F (2013) Streptomyces spp., as efficient expression system for a D, D-peptidase/D, D-carboxypeptidase involved in glycopeptide antibiotic resistance. BMC Biotechnol 13:24
11. Boeck LD, Mertz FP (1986) A47934, a novel glycopeptide-aglycone antibiotic produced by a strain of Streptomyces toyocaensis taxonomy and fermentation studies. J Antibiot (Tokyo) 39:1533-1540
12. Borghi A, Edwards D, Zerilli LF, Lancini GC (1991) Factors affecting the normal and branchedchain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus. J Gen Microbiol 137:587-592
13. Bouza E, Burillo A (2010) Oritavancin: A novel lipoglycopeptide active against gram-positive pathogens including multiresistant strains. Int J Antimicrob Agents 36:401-407
14. Bugg TD, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT (1991) Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30:10408-10415
15. Chan HC, Huang YT, Lyu SY, Huang CJ, Li YS, Liu YC, Chou CC, Tsai MD, Li TL (2011) Regioselective deacetylation based on teicoplanin-complexed orf2 crystal structures. Mol BioSyst 7:1224-1231
16. Choroba OW, Williams DH, Spencer JB (2000) Biosynthesis of the vancomycin group of antibiotics: involvement of an unusual dioxygenase in the pathway to (s)-4-hydroxyphenylglycine. J Am Chem Soc 122:5389-5390
17. Crowley BM, Boger DL (2006) Total synthesis and evaluation of [psi[ch2nh]tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding. J Am Chem Soc 128:2885-2892
18. D'Costa VM, King CE, Kalan L, Morar M, Sung WW, Schwarz C, Froese D, Zazula G, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD (2011) Antibiotic resistance is ancient. Nature 477:457-461
19. Ehrenkranz NJ (1958) The clinical evaluation of vancomycin in treatment of multi-antibiotic refractory staphylococcal infections. Antibiot Annu 6:587-594
20. Evers S, Quintiliani R, Courvalin P (1996) Genetics of glycopeptide resistance in enterococci. Microb Drug Resist 2:219-223
21. Fu X, Albermann C, Jiang J, Liao J, Zhang C, Thorson JS (2003) Antibiotic optimization via in vitro glycorandomization. Nat Biotechnol 21:1467-1469
22. Geraci JE, Hermans PE (1983) Vancomycin. Mayo Clin Proc 58:88-91
23. Goldstein BP, Selva E, Gastaldo L, Berti M, Pallanza R, Ripamonti F, Ferrari P, Denaro M, Arioli V, Cassani G (1987) A40926, a new glycopeptide antibiotic with anti-Neisseria activity. Antimicrob Agents Chemother 31:1961-1966
24. Gravet A, Rondeau M, Harf-Monteil C, Grunenberger F, Monteil H, Scheftel JM, Prévost G (1999) Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin lukE-lukD. J Clin Microbiol 37:4012-4019
25. Grdadolnik SG, Pristovsek P, Mierke DF (1998) Vancomycin: Conformational consequences of the sugar substituent. J Med Chem 41:2090-2099
26. Guskey MT, Tsuji BT (2010) A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin. Pharmacotherapy 30:80-94
27. Hammond SJ, Williamson MP, Williams DH, Boeck LD, Marconi GG (1982) On the biosynthesis of the antibiotic vancomycin. J Chem Soc Chem Commun 344-346
28. Healy VL, Lessard IA, Roper DI, Knox JR, Walsh CT (2000) Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis. Chem Biol 7:R109-R119
29. Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE, Gao Q, Cass RT, Karr DE, Benton BM, Humphrey PP (2005) Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49:1127-1134
30. Hong HJ, Hutchings MI, Neu JM, Wright GD, Paget MS, Buttner MJ (2004) Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol Microbiol 52:1107-1121
31. Hong HJ, Hutchings MI, Hill LM, Buttner MJ (2005) The role of the novel fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J Biol Chem 280:13055-13061
32. Hong HJ, Hutchings MI, Buttner MJ (2008) Vancomycin resistance vanS/vanR two-component systems. Adv Exp Med Biol 631:200-213
33. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23:99-139
34. Hutchings MI, Hong HJ, Buttner MJ (2006) The vancomycin resistance VanRS two-component signal transduction system of Streptomyces coelicolor. Mol Microbiol 59:923-935
35. James RC, Pierce JG, Okano A, Xie J, Boger DL (2012) Redesign of glycopeptide antibiotics: back to the future. ACS Chem Biol 7:797-804
36. Jovetic S, Zhu Y, Marcone GL, Marinelli F, Tramper J (2010) b-lactam and glycopeptide antibiotics: first and last line of defense? Trends Biotechnol 28:596-604
37. Kahne D, Leimkuhler C, Lu W, Walsh C (2005) Glycopeptide and lipoglycopeptide antibiotics. Chem Rev 105:425-448
38. Kalan L, Perry J, Koteva K, Thaker M, Wright G (2013) Glycopeptide sulfation evades resistance. J Bacteriol 195:167-171
39. Kruse H, Johansen BK, Rørvik LM, Schaller G (1999) The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant enterococcus species in norwegian poultry and swine production. Microb Drug Resist 5:135-139
40. Labeda DP (1995) Amycolatopsis coloradensis sp. nov., the avoparcin (ll-av290)-producing strain. Int J Syst Bact 45:124-127
41. Lamb SS, Patel T, Koteva KP, Wright GD (2006) Biosynthesis of sulfated glycopeptide antibiotics by using the sulfotransferase stal. Chem Biol 13:171-181
42. Lancini G, Demain A (2006) Bacterial pharmaceutical products. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E (eds) The Prokaryotes. Vol 1: Symbiotic assosiations, biotechnology, applied microbiology. Springer, Heidelberg
43. Leadbetter MR, Adams SM, Bazzini B, Fatheree PR, Karr DE, Krause KM, Lam BM, Linsell MS, Nodwell MB, Pace JL, Quast K, Shaw JP, Soriano E, Trapp SG, Villena JD, Wu TX, Christensen BG, Judice JK (2004) Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (td-6424). J Antibiot (Tokyo) 57:326-336
44. Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, Leclercq R, Courvalin P, Cattoir V (2011) D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 55:4606-4612
45. Lessard IA, Walsh CT (1999) Mutational analysis of active-site residues of the enterococcal DAla-D-Ala dipeptidase VanX and comparison with Escherichia coli D-Ala-D-Ala ligase and DAla-D-Ala carboxypeptidase VanY. Chem Biol 6:177-187
46. Levine DP (2006) Vancomycin: A history. Clin Infect Dis 42(Suppl 1):S5-S12
47. Li TL, Huang F, Haydock SF, Mironenko T, Leadlay PF, Spencer JB (2004) Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin: Characterization of two glycosyltransferases and the key acyltransferase. Chem Biol 11:107-119
48. Li TL, Liu YC, Lyu SY (2012) Combining biocatalysis and chemoselective chemistries for glycopeptide antibiotics modification. Curr Opin Chem Biol 16:170-178
49. Liu YC, Li YS, Lyu SY, Hsu LJ, Chen YH, Huang YT, Chan HC, Huang CJ, Chen GH, Chou CC, Tsai MD, Li TL (2011) Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds. Nat Chem Biol 7:304-309
50. Lu K, Asano R, Davies J (2004) Antimicrobial resistance gene delivery in animal feeds. Emerg Infect Dis 10:679-683
51. Mackay JP, Gerhard U, Beauregard DA, Maplestone RA, Williams DH (1994a) Dissection of the contributions toward dimerization of glycopeptide antibiotics. J Am Chem Soc 116:4573-4580
52. Mackay JP, Gerhard U, Beauregard DA, Westwell MS, Searle MS, Williams DH (1994b) Glycopeptide antibiotic activity and the possible role of dimerization: A model for biological signaling. J Am Chem Soc 116:4581-4590
53. Malabarba A, Nicas TI, Thompson RC (1997) Structural modifications of glycopeptide antibiotics. Med Res Rev 17:69-137
54. Malabarba A, Ciabatti R (2001) Glycopeptide derivatives. Curr Med Chem 8:1759-1773
55. Malabarba A, Goldstein BP (2005) Origin, structure, and activity in vitro and in vivo of dalbavancin. J Antimicrob Chemother 55(Suppl 2):15-20
56. Marcone GL, Beltrametti F, Binda E, Carrano L, Foulston L, Hesketh A, Bibb M, Marinelli F (2010) Novel mechanism of glycopeptide resistance in the A40926 producer Nonomuraea sp. ATCC 39727. Antimicrob Agents Chemother 54:2465-2472
57. Marshall CG, Lessard IA, Park I, Wright GD (1998) Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob Agents Chemother 42:2215-2220
58. Matsuzaki K, Ikeda H, Ogino T, Matsumoto A, Woodruff HB, Tanaka H, Omura S (1994) Chloropeptins I and II, novel inhibitors against gp120-CD4 binding from Streptomyces sp. J Antibiot (Tokyo) 47:1173-1174
59. McCormick MH, McGuire JM, Pittenger GE, Pittenger RC, Stark WM (1955) Vancomycin, a new antibiotic. I. Chemical and biological properties. Antibiot Annu 3:606-611
60. Neu HC, Prince A, Neu CO, Garvey GJ (1977) Incidence of diarrhea and colitis associated with clindamycin therapy. J Infect Dis 135(Suppl):S120-S125
61. Nicolaou KC, Boddy CN, Bräse S, Winssinger N (1999) Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew Chem Int Ed Engl 38:2096-2152
62. Nitanai Y, Kikuchi T, Kakoi K, Hanamaki S, Fujisawa I, Aoki K (2009) Crystal structures of the complexes between vancomycin and cell-wall precursor analogs. J Mol Biol 385:1422-1432
63. Novotna G, Hill C, Vincent K, Liu C, Hong HJ (2012) A novel membrane protein, VanJ, conferring resistance to teicoplanin. Antimicrob Agents Chemother 56:1784-1796
64. Pace JL, Yang G (2006) Glycopeptides: update on an old successful antibiotic class. Biochem Pharmacol 71:968-980
65. Pantosti A, Del Grosso M, Tagliabue S, Macrì A, Caprioli A (1999) Decrease of vancomycinresistant enterococci in poultry meat after avoparcin ban. Lancet 354:741-742
66. Parenti F, Beretta G, Berti M, Arioli V (1978) Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov, Sp. I. Description of the producer strain, fermentation studies and biological properties. J Antibiot 31:276-283
67. Parenti F, Schito GC, Courvalin P (2000) Teicoplanin chemistry and microbiology. J Chemother 12:5-14
68. Peacock JE, Marsik FJ, Wenzel RP (1980) Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 93:526-532
69. Peetermans WE, Hoogeterp JJ, Hazekamp-van Dokkum AM, van den Broek P, Mattie H (1990) Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection. Antimicrob Agents Chemother 34:1869-1874
70. Pelzer S, Süssmuth R, Heckmann D, Recktenwald J, Huber P, Jung G, Wohlleben W (1999) Identification and analysis of the balhimycin biosynthetic gene cluster and its use for manipulating glycopeptide biosynthesis in Amycolatopsis mediterranei DSM 5908. Antimicrob Agents Chemother 43:1565-1573
71. Pensack JM, Wang GT, Simkins L (1982) Avoparcin-A growth-promoting feed antibiotic for broiler chickens. Poult Sci 61:1009-1012
72. Périchon B, Courvalin P (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:4580-4587
73. Pootoolal J, Thomas MG, Marshall CG, Neu JM, Hubbard BK, Walsh CT, Wright GD (2002) Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL 15009. Proc Natl Acad Sci USA 99:8962-8967
74. Prince AS, Neu HC (1979) Antibiotic-associated pseudomembranous colitis in children. Pediatr Clin North Am 26:261-268
75. Puk O, Huber P, Bischoff D, Recktenwald J, Jung G, Süssmuth RD, van Pée KH, Wohlleben W, Pelzer S (2002) Glycopeptide biosynthesis in Amycolatopsis mediterranei DSM 5908: function of a halogenase and a haloperoxidase/perhydrolase. Chem Biol 9:225-235
76. Puk O, Bischoff D, Kittel C, Pelzer S, Weist S, Stegmann E, Süssmuth RD, Wohlleben W (2004) Biosynthesis of chloro-beta-hydroxytyrosine, a nonproteinogenic amino acid of the peptidic backbone of glycopeptide antibiotics. J Bacteriol 186:6093-6100
77. Retzlaff L, Distler J (1995) The regulator of streptomycin gene expression, StrR of Streptomyces griseus is a DNA binding activator protein with multiple recognition sites. Mol Microbiol 18:151-162
78. Reynolds PE, Courvalin P (2005) Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob Agents Chemother 49:21-25
79. Rybak MJ, Bailey EM, Warbasse LH (1992) Absence of ''Red man syndrome'' in patients being treated with vancomycin or high-dose teicoplanin. Antimicrob Agents Chemother 36:1204-1207
80. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E (1982a) Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med 96:11-16
81. Saravolatz LD, Pohlod DJ, Arking LM (1982b) Community-acquired methicillin-resistant Staphylococcus aureus infections: A new source for nosocomial outbreaks. Ann Intern Med 97:325-329
82. Schäberle TF, Vollmer W, Frasch HJ, Hüttel S, Kulik A, Röttgen M, von Thaler AK, Wohlleben W, Stegmann E (2011) Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycina. Antimicrob Agents Chemother 55:4283-4289
83. Schäfer M, Schneider TR, Sheldrick GM (1996) Crystal structure of vancomycin. Structure 4:1509-1515
84. Sosio M, Stinchi S, Beltrametti F, Lazzarini A, Donadio S (2003) The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by Nonomuraea species. Chem Biol 10:541-549
85. Sosio M, Kloosterman H, Bianchi A, de Vreugd P, Dijkhuizen L, Donadio S (2004) Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus. Microbiology 150:95-102
86. Stegmann E, Frasch HJ, Wohlleben W (2010) Glycopeptide biosynthesis in the context of basic cellular functions. Curr Opin Microbiol 13:595-602
87. Sujatha S, Praharaj I (2012) Glycopeptide resistance in Gram-positive cocci: A review. Interdiscip Perspect Infect Dis 2012:781679
88. Süssmuth RD, Wohlleben W (2004) The biosynthesis of glycopeptide antibiotics-A model for complex, non-ribosomally synthesized, peptidic secondary metabolites. Appl Microbiol Biotechnol 63:344-350
89. Taurino C, Frattini L, Marcone GL, Gastaldo L, Marinelli F (2011) Actinoplanes teichomyceticus ATCC 31121 as a cell factory for producing teicoplanin. Microb Cell Fact 10:82
90. Thaker MN, Wright GD (2012) Opportunities for synthetic biology in antibiotics: expanding glycopeptide chemical diversity. ACS Synth Biol doi:10.1021/sb300092n
91. Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J (1989) High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 103:173-181
92. Van Bambeke F (2006) Glycopeptides and glycodepsipeptides in clinical development: A comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy. Curr Opin Investig Drugs 7:740-749
93. Van Hal SJ, Paterson DL (2011) New Gram-positive antibiotics: better than vancomycin? Curr Opin Infect Dis 24:515-520
94. Van Wageningen AM, Kirkpatrick PN, Williams DH, Harris BR, Kershaw JK, Lennard NJ, Jones M, Jones SJ, Solenberg PJ (1998) Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic. Chem Biol 5:155-162
95. Vollmer W, Blanot D, de Pedro MA (2008) Peptidoglycan structure and architecture. FEMS Microbiol Rev 32:149-167
96. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC (2003) Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569-1571
97. Williams DH, Searle MS, Mackay JP, Gerhard U, Maplestone RA (1993) Toward an estimation of binding constants in aqueous solution: Studies of associations of vancomycin group antibiotics. Proc Natl Acad Sci USA 90:1172-1178
98. Wohlleben W, Stegmann E, Süssmuth RD (2009) Chapter 18. Molecular genetic approaches to analyze glycopeptide biosynthesis. Methods Enzymol 458:459-486
99. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F, Jacoby GA, Wang M (2010) vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 54:4643-4647
100. Zhanel GG, Calic D, Schweizer F, Zelenitsky S, Adam H, Lagacé-Wiens PR, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA (2010) New lipoglycopeptides: A comparative review of dalbavancin, oritavancin and telavancin. Drugs 70:859-886